AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
05 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
04 Jan 2011 04:00 PM
RNS
Total Voting Rights
24 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
23 Dec 2010 02:30 PM
RNS
Share Repurchase Programme
23 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
23 Dec 2010 07:00 AM
RNS
Ends Agreement with Abbott fo
22 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
21 Dec 2010 07:00 AM
RNS
Update re motavizumab
21 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
20 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
17 Dec 2010 05:15 PM
RNS
Directorate Change
17 Dec 2010 07:00 AM
RNS
Complete Response Letter from
16 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
14 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
13 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
10 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
09 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
08 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
07 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
06 Dec 2010 07:00 AM
RNS
EC approves Brilique tablets
06 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
03 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
02 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
01 Dec 2010 05:00 PM
RNS
Director/PDMR Shareholding
01 Dec 2010 04:00 PM
RNS
Total Voting Rights
01 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
30 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
29 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
26 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
25 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
24 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
23 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
22 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
19 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
18 Nov 2010 04:00 PM
RNS
Director/PDMR Shareholding
18 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
17 Nov 2010 04:00 PM
RNS
Director/PDMR Shareholding
17 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
16 Nov 2010 04:00 PM
RNS
Director/PDMR Shareholding
16 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
15 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
12 Nov 2010 04:00 PM
RNS
Director/PDMR Shareholding
12 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
11 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
10 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
09 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
08 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
05 Nov 2010 03:54 PM
RNS
US FDA approves KOMBIGLYZE XR
05 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
04 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100